A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activity

被引：0

作者：

Eleftherios Kostaras

Teresa Kaserer

Glorianne Lazaro

Sara Farrah Heuss

Aasia Hussain

Pedro Casado

Angela Hayes

Cihangir Yandim

Nicolaos Palaskas

Yi Yu

Brian Schwartz

Florence Raynaud

Yuen-Li Chung

Pedro R. Cutillas

Igor Vivanco

机构：

[1] The Institute of Cancer Research,Division of Cancer Therapeutics

[2] The Institute of Cancer Research,Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics

[3] Center for Molecular Biosciences,Department of Pharmacology and Toxicology, Institute of Pharmacy

[4] University of Innsbruck,Centre for Haemato

[5] Queen Mary University of London,Oncology, Barts Cancer Institute

[6] David Geffen School of Medicine at UCLA,Division of Hematology and Oncology

[7] ArQule,Cancer Research UK Cancer Imaging Centre, Division of Radiotherapy and Imaging

[8] Inc. (a wholly-owned subsidiary of Merck & Co.,Department of Genetics and Bioengineering, Faculty of Engineering

[9] Inc.,undefined

[10] Kenilworth,undefined

[11] NJ,undefined

[12] USA),undefined

[13] The Institute of Cancer Research London and Royal Marsden Hospital,undefined

[14] Izmir University of Economics,undefined

来源：

British Journal of Cancer | 2020年 / 123卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：542 / 555

页数：13

共 50 条

[1] A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activity
Kostaras, Eleftherios
Kaserer, Teresa
Lazaro, Glorianne
Heuss, Sara Farrah
Hussain, Aasia
Casado, Pedro
Hayes, Angela
Yandim, Cihangir
Palaskas, Nicolaos
Yu, Yi
Schwartz, Brian
Raynaud, Florence
Chung, Yuen-Li
Cutillas, Pedro R.
Vivanco, Igor
BRITISH JOURNAL OF CANCER, 2020, 123 (04) : 542 - 555
[2] Synthesis, Biological Activity Evaluation and Molecular Modeling Study on the New Isoconessimine Derivatives as Acetylcholinesterase Inhibitors
Jin, Guofei
Yang, Zhongduo
Xue, Weiwei
Sheng, Jie
Shi, Yin
Yao, Xiaojun
CHINESE JOURNAL OF CHEMISTRY, 2013, 31 (09) : 1228 - 1233
[3] Design, Synthesis, Biological Evaluation, and Molecular Docking of Novel Benzopyran and Phenylpyrazole Derivatives as Akt Inhibitors
Zhan, Wenhu
Lin, Sendong
Chen, Jing
Dong, Xiaowu
Chu, Jianbo
Du, Wenting
CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (06) : 770 - 779
[4] Molecular insight on the molecular mechanisms for the biological activity of dendritic amphiphiles on biological membranes
Sum, Amadeu
Gandour, Richard
Karlovska, J.
Balgavy, Pavel
CHEMISTRY AND PHYSICS OF LIPIDS, 2007, 149 : S44 - S44
[5] Synthesis and biological evaluation of a new class of azole urea compounds as Akt inhibitors with promising anticancer activity in pancreatic cancer models
Pecoraro, Camilla
Sciano, Fabio
Carbone, Daniela
Xu, Geng
Deng, Juan
Cascioferro, Stella
Giovannetti, Elisa
Diana, Patrizia
Parrino, Barbara
BIOORGANIC CHEMISTRY, 2024, 153
[6] Synthesis, biological activity and molecular docking of new tricyclic series as α-glucosidase inhibitors
Hatem A. Abuelizz
Nor Azman N. I. Iwana
Rohaya Ahmad
El-Hassane Anouar
Mohamed Marzouk
Rashad Al-Salahi
BMC Chemistry, 13
[7] Synthesis, biological activity and molecular docking of new tricyclic series as α-glucosidase inhibitors
Abuelizz, Hatem A.
Iwana, Nor Azman N. I.
Ahmad, Rohaya
Anouar, El-Hassane
Marzouk, Mohamed
Al-Salahi, Rashad
BMC CHEMISTRY, 2019, 13 (1)
[8] NEW ADENOSINE KINASE INHIBITORS WITH ORAL ANTIINFLAMMATORY ACTIVITY - SYNTHESIS AND BIOLOGICAL EVALUATION
COTTAM, HB
WASSON, DB
SHIH, HC
RAYCHAUDHURI, A
DIPASQUALE, G
CARSON, DA
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (22) : 3424 - 3430
[9] AN EVALUATION OF THE PHARMACOLOGIC ACTIVITY OF A NEW SERIES OF CHALCONE DERIVATIVES
ROSSI, GV
PACKMAN, EW
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1958, 47 (09): : 640 - 645
[10] Synthesis and biological activity of Akt/PI3K inhibitors
Redaelli, C.
Granucci, F.
De Gioia, L.
Cipolla, L.
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (10) : 1127 - 1136

← 1 2 3 4 5 →